Deepwise Named to Deloitte's 2018 China Rising Star List Amid IPO Filing

VCBeat (WeChat ID: vcbeat) has learned that on November 20, 2018, the Deloitte Technology Fast 50 China 2018 and Rising Stars Award Ceremony was held in Beijing. The first half of the event featured lively roundtable discussions on the hottest topics in the technology sector, while the second half saw the release of the “Deloitte Technology Fast 50 China 2018 Report.” Awards such as the Top 50 Rising Stars of China 2018 were also presented at the ceremony. Deepwise Medical, along with 49 other outstanding enterprises in the technology sector, was selected as one of the “Top 50 Rising Stars of China” (the complete list is attached at the end of this article). This award aims to recognize outstanding companies that, despite being recently established, have already achieved leadership in their respective niche markets and possess significant growth potential.

The Deloitte Technology Fast 500, a premier global ranking of high-growth companies, originated in Silicon Valley, USA, and is conducted annually in over 30 countries, including the United States, the United Kingdom, Germany, Japan, Australia, and China. Hailed by international mainstream media as the “benchmark for high-growth companies worldwide” and the “Oscars of the tech industry,” the program has featured numerous industry leaders on its past lists. Companies such as Apple, Google, Microsoft, Amazon, Facebook, Tencent, Alibaba, Baidu, JD.com, Hikvision, Didi, Toutiao, and Qihoo 360 have all been included in the rankings. As many selected companies are in their early stages of rapid growth, the award is also known as the “cradle of future stars.” Companies participating in the Deloitte China Technology Fast 50 will become candidates for the Deloitte Technology Fast 500 Asia Pacific.

Mr. Li Yiming, CTO of Deepwise Medical, was invited to participate in the roundtable discussion titled “Intelligent Healthcare Services: Exploring the Real Demands Behind Market Prosperity.” He stated that the evolution from internet healthcare to medical artificial intelligence represents an upgrade of the healthcare industry from superficial to substantive levels. The penetration of AI into healthcare is expected to significantly transform the cost and efficiency of medical services, fundamentally address the supply bottlenecks of healthcare resources, and alleviate the difficulty of accessing medical care.

The award selection process involved rigorous multi-tiered screening. To qualify for the 2018 China Rising Stars award, companies were required to possess leading-edge technology and a viable business model; operate in a niche segment with substantial growth potential where the company holds a leading position; and have their headquarters located in mainland China, Hong Kong, or Macau. Key evaluation criteria included the founding team, technological innovation, industry prospects, and corporate valuation—four areas that constitute Deepwise Medical’s core strengths. Originating from the Peking University Artificial Intelligence Innovation Center, Deepwise Medical is dedicated to developing medical products based on cutting-edge artificial intelligence technologies.

Since its establishment in March 2017, Deepwise has grown to a team of 200 employees, with researchers accounting for 80% of the workforce. Its roster of master’s and doctoral degree holders is second to none in the industry, serving as a crucial guarantee for Deepwise’s core technological strength. The founding team comprises four core founders: Mr. Lei Ming, one of Baidu’s original “Seven Swords,” serves as Chairman; Mr. Qiao Xin, former Vice President of Siemens Northeast Asia and General Manager of the Healthcare and CT Business Unit, serves as CEO; Mr. Li Yiming, who previously worked at Baidu and served as General Manager of the Search and Data Departments at AutoNavi, serves as CTO; and Professor Yu Yizhou, an ACM (Association for Computing Machinery) Distinguished Scientist, serves as Chief Scientist of Deepwise Medical. Together, these four leaders provide Deepwise with significant advantages in terms of industry foresight, technological leadership, product practicality, and speed of commercial deployment.

As reflected in the event’s theme, “From Unicorn to Qianlima, From Good to Great,” Deepwise Medical is striding confidently toward the future.